Emcure Pharma IPO 2024: Comprehensive Overview
Company Overview
Emcure Pharmaceuticals Limited, founded in 1981, is a leading Indian pharmaceutical company that develops, manufactures, and markets a wide range of pharmaceutical products globally. Emcure’s product portfolio covers several therapeutic areas, including gynecology, cardiovascular, vitamins, minerals, HIV antivirals, blood products, and oncology. As of September 2023, Emcure ranked 13th in domestic sales among Indian pharmaceutical companies and held the top position in gynecology and HIV antiviral therapeutic areas.
Emcure Pharma IPO Details
- IPO Date: July 3, 2024 to July 5, 2024
- Issue Size: ₹1,952.03 Crores
- Fresh Issue: 0.79 Crore shares aggregating to ₹800.00 Crores
- Offer for Sale: 1.14 Crore shares aggregating to ₹1,152.03 Crores
- Price Band: ₹960 to ₹1008 per share
- Lot Size: 14 Shares
- Minimum Investment: ₹14,112
- Listing At: BSE, NSE
Key Dates
- Basis of Allotment: July 8, 2024
- Initiation of Refunds: July 9, 2024
- Credit of Shares to Demat: July 9, 2024
- Listing Date: July 10, 2024
Reservation and Allocation
- QIB Shares Offered: Not more than 50% of the Net Issue
- Retail Shares Offered: Not less than 35% of the Net Issue
- NII (HNI) Shares Offered: Not more than 15% of the Net Issue
Financial Information (Restated Consolidated)
| Period Ended | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
|---|---|---|---|
| Assets | ₹7,806.16 Cr | ₹6,672.53 Cr | ₹6,063.47 Cr |
| Revenue | ₹6,715.24 Cr | ₹6,031.72 Cr | ₹5,918.86 Cr |
| Profit After Tax | ₹527.58 Cr | ₹561.85 Cr | ₹702.56 Cr |
| Net Worth | ₹2,952.28 Cr | ₹2,501.13 Cr | ₹1,987.55 Cr |
| Reserves and Surplus | ₹2,722.40 Cr | ₹2,293.77 Cr | ₹1,791.03 Cr |
| Total Borrowing | ₹2,091.94 Cr | ₹2,202.42 Cr | ₹2,102.19 Cr |
Key Performance Indicators
- ROE: 16.90%
- ROCE: 19.37%
- Debt/Equity: 0.67
- RoNW: 16.87%
- P/BV: 6.18
IPO Grey Market Premium (GMP)
- GMP: ₹295 as of July 2, 2024
- Expected Listing Gain: 29.27%
Promoters
- Satish Mehta and Sunil Mehta
Utilization of Funds
The funds raised through the IPO will be used for:
- Repayment and/or prepayment of certain outstanding borrowings.
- General corporate purposes.
Lead Managers
- Kotak Mahindra Capital Company Limited
- Axis Capital Limited
- J.P. Morgan India Private Limited
- Jefferies India Private Limited
Registrar
- Link Intime India Private Ltd
- Phone: +91-22-4918 6270
- Email: emcure.ipo@linkintime.co.in
- Website: Link Intime
Company Contact Details
- Address: Plot No. P-1 and P-2, IT-BT Park, Phase II, M.I.D.C., Hinjawadi, Pune – 411 057
- Phone: +91 20 3507 0033
- Email: investors@emcure.co.in
- Website: Emcure Pharmaceuticals
Recommendation
Emcure Pharmaceuticals’ IPO is attractive for medium to long-term investors, given the company’s strong market position and growth in top-line revenues. The reduction in debt post-IPO is expected to enhance profitability. Based on the FY24 earnings, the issue appears fully priced.
For detailed information, refer to the Emcure Pharma IPO RHP.
Emcure Pharma IPO Lot Size
Investors can bid for a minimum of 14 shares and in multiples thereof. Below is the table depicting the minimum and maximum investment by retail investors and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 14 | 14,112 |
| Retail (Max) | 14 | 196 | 197,568 |
| S-HNI (Min) | 15 | 210 | 211,680 |
| S-HNI (Max) | 70 | 980 | 987,840 |
| B-HNI (Min) | 71 | 994 | 1,001,952 |
Emcure Pharma IPO Promoter Holding
- Pre Issue Holding: 98.90%
- Post Issue Holding: To be updated after allotment.
By combining the detailed information, potential investors can get a comprehensive understanding of the Emcure Pharma IPO and make informed investment decisions.
For more IPO details plz visit https://undergroundfinanceinsight.com/
Frequently Asked Questions (FAQs) About Emcure Pharma IPO
1. What are the key dates for the Emcure Pharma IPO?
- IPO Opening Date: July 3, 2024
- IPO Closing Date: July 5, 2024
- Basis of Allotment: July 8, 2024
- Initiation of Refunds: July 9, 2024
- Credit of Shares to Demat: July 9, 2024
- Listing Date: July 10, 2024
2. What is the price band for the Emcure Pharma IPO?
The price band for the Emcure Pharma IPO is set between ₹960 and ₹1008 per share.
3. What is the lot size and minimum investment required?
- Lot Size: 14 shares
- Minimum Investment for Retail Investors: ₹14,112 (1 lot)
4. What is the objective of the Emcure Pharma IPO?
The funds raised from the IPO will be used for:
- Repayment and/or prepayment of certain outstanding borrowings.
- General corporate purposes.
5. Who are the lead managers for the Emcure Pharma IPO?
The lead managers for the IPO are:
- Kotak Mahindra Capital Company Limited
- Axis Capital Limited
- J.P. Morgan India Private Limited
- Jefferies India Private Limited
6. How can I apply for the Emcure Pharma IPO?
Investors can apply for the Emcure Pharma IPO through ASBA (Application Supported by Blocked Amount) available via net banking or by submitting a physical IPO application form to their broker or bank. Ensure you have a demat account for the shares to be credited upon allotment.
